The year 2025 has been a significant one for the Indian pharmaceutical sector. It witnessed several novel launches, ...

The pharmaceutical industry requires rapid training to address workforce shortages for new US manufacturing facilities, ...

The complainant, a retired district attorney suffering from multiple age-related ailments, had purchased ORO Plus tablets ...

FDA has taken steps to embrace AI in 2025, announcing in December that it will be providing agency staff with agentic AI ...

Sun Pharma-owned Taro Pharmaceutical is recalling over 17,000 units of antifungal Ciclopirox Shampoo in the US due to ...

Taro Pharmaceutical Industries, a unit of Sun Pharma, is recalling over 17,000 units of an antifungal medication in the US ...

We are all faced with a series of great opportunities—brilliantly disguised as insoluble problems.” - John W. Gardner Rich ...

Teva Pharmaceutical Indus (NYSE: TEVA) has outperformed the market over the past 5 years by 13.95% on an annualized basis producing an average annual return of 27.15%. Currently, Teva Pharmaceutical ...

The Class II recall, which began on December 9, addresses potential temporary health consequences from the product.

As the Schedule M deadline ends this month, only around 1,700 of India's 8,500 MSME drug manufacturers are expected to comply ...

Eu, a fourth-generation descendant of Eu Yan Sang founder Eu Kong, joined the family’s TCM business in 1989 following an 18-year career across merchant banking, stockbroking and consulting at a time ...

China's drug regulator has also accelerated approvals of domestically developed innovative products. The National Medical ...